Invention Grant
- Patent Title: Methods of assessing nuclease cleavage
-
Application No.: US16475862Application Date: 2018-01-05
-
Publication No.: US12110545B2Publication Date: 2024-10-08
- Inventor: Georgia Giannoukos , Christopher Wilson , Dawn Ciulla
- Applicant: Editas Medicine, Inc.
- Applicant Address: US MA Cambridge
- Assignee: Editas Medicine, Inc.
- Current Assignee: Editas Medicine, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Choate, Hall & Stewart LLP
- Agent Rolando Medina; Meaghan E. Bychowski
- International Application: PCT/US2018/012652 2018.01.05
- International Announcement: WO2018/129368A 2018.07.12
- Date entered country: 2019-07-03
- Main IPC: C12Q1/6869
- IPC: C12Q1/6869 ; G16B20/50 ; G16B30/10
Abstract:
The present disclosure relates to methods of analyzing activity of nucleases, such as ZFNs, TALENs or CRISPR-associated nucleases, in particular their cutting at “off-target” loci.
Public/Granted literature
- US20200232022A1 METHODS OF ASSESSING NUCLEASE CLEAVAGE Public/Granted day:2020-07-23
Information query
